glp-1 industry Receptor Agonist Market Size & Analysis, 2026-2033 Demand for GLP-1 presents challenges

If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial

Kanou M, Nakamura K, Horie K, Sakai H, Yanagihara Y, Sakakibara I, et al

Patients assigned to tirzepatide showed a 20.9% BW loss after 36 weeks with an additional 5.5% reduction after 52 weeks, while those who switched to placebo experienced a 14% weight regain, confirming the findings from STEP 4 supporting the chronicity of obesity and the need for continuous treatment

They look better and feel better almost immediately